When did Citius Oncology (CTOR) last report earnings?

Citius Oncology last reported on Aug 12, 2025, covering fiscal Q3 2025.

Did CTOR beat earnings estimates?

Yes. Citius Oncology reported EPS of −$0.08 for Q3 2025 against a −$0.15 estimate — a 46.67% beat.

Citius Oncology (CTOR) earnings history

Most recent quarter

Fiscal period: Q3 2025
Period end: Jun 30, 2025
EPS actual: −$0.08
EPS estimate: −$0.15
EPS surprise: +46.67%
Revenue surprise: +0.00%
Revenue: $0.00
Revenue estimate: $0.00
Reported: Aug 12, 2025
SEC filing: View filing

Earnings history

Period	Reported	EPS estimate	EPS actual	Surprise	Revenue	Filing
Q3 2025	Aug 12, 2025	−$0.15	−$0.08	+46.67%	$0.00	SEC
Q2 2025	May 14, 2025	−$0.09	−$0.11	−22.22%	$0.00	SEC
Q1 2025	Feb 14, 2025	−$0.06	−$0.09	−50.00%	$0.00	SEC

Quarterly revenue

Q1 2025

$0.00

Q2 2025

$0.00

Q3 2025

$0.00

Frequently asked questions

When did Citius Oncology (CTOR) last report earnings?
Citius Oncology last reported on Aug 12, 2025, covering fiscal Q3 2025.
Did CTOR beat earnings estimates?
Yes. Citius Oncology reported EPS of −$0.08 for Q3 2025 against a −$0.15 estimate — a 46.67% beat.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by